α-Mangostin Synergizes the Antineoplastic Effects of 5-Fluorouracil Allowing a Significant Dose Reduction in Breast Cancer Cells

α-Mangostin Synergizes the Antineoplastic Effects of 5-Fluorouracil Allowing a Significant Dose Reduction in Breast Cancer Cells

Breast cancer is the most common neoplasm and the leading cause of cancer death in women worldwide. Although 5-fluorouracil is a conventional chemotherapeutic agent for breast cancer treatment, its use may result in severe side effects. Thus, there is widespread interest in lowering 5-fluorouracil d...

Full description

Bibliographic Details
Main Authors: Galia Lara-Sotelo, Lorenza Díaz, Rocío García-Becerra, Euclides Avila, Heriberto Prado-Garcia, Gabriela Morales-Guadarrama, María de Jesús Ibarra-Sánchez, José Esparza-López, Fernando Larrea, Janice García-Quiroz
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Processes
Subjects:
α-mangostin
breast cancer
combination index
dose-reduction index
5-fluorouracil
Online Access:https://www.mdpi.com/2227-9717/9/3/458

Internet

https://www.mdpi.com/2227-9717/9/3/458

Similar Items